Amgen, Inc. recalls AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only
Recalled December 28, 2016 · FDA recall D-0226-2017 · Amgen
Hazard
Lack of Assurance of Sterility: Potential cracks in glass vials · FDA Class II
Units
11,434 vials
Sold at
United States and Puerto Rico No foreign distribution.
Description
Lack of Assurance of Sterility: Potential cracks in glass vials
Product
AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01
Manufacturer(s)
Amgen, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →